{"id":371521,"date":"2026-06-23T14:41:07","date_gmt":"2026-06-23T14:41:07","guid":{"rendered":"https:\/\/www.newsbeep.com\/us-ca\/371521\/"},"modified":"2026-06-23T14:41:07","modified_gmt":"2026-06-23T14:41:07","slug":"ucla-and-childrens-hospital-los-angeles-chla-awarded-up-to-17-25-million-grant-to-participate-in-autism-clinical-trials-network-neurology","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us-ca\/371521\/","title":{"rendered":"UCLA and Children\u2019s Hospital Los Angeles (CHLA) awarded up to $17.25 million grant to participate in autism clinical trials network &#8211; Neurology"},"content":{"rendered":"<p>Key takeaways<\/p>\n<p>UCLA\/CHLA have been selected to partner as one of the first 12 international sites to participate in the ARIA IMPACT Network, a major effort to advance autism research.The funding supports a\u00a0short-term\u00a0natural history and clinical endpoint\u00a0study of patients with autism and related neurodevelopmental conditions, combining clinical assessments, biological data and open data sharing.UCLA also serves as the Clinical Coordinating Center, providing oversight and infrastructure to the IMPACT sites.<\/p>\n<p>UCLA and Children\u2019s Hospital Los Angeles (CHLA) have received an up to $17.25 million grant from \u00a0<a href=\"https:\/\/ariaroadmap.org\/\" rel=\"nofollow noopener\" target=\"_blank\">Aligning Research to Impact Autism (ARIA)<\/a> to serve as a combined research site in the <a href=\"https:\/\/ariaroadmap.org\/research-hubs\/impact-network\/\" rel=\"nofollow noopener\" target=\"_blank\">Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network<\/a>. Together, UCLA and CHLA form the IMPACT-LA site,\u00a0one of 12 initial\u00a0sites worldwide chosen to accelerate clinical trial readiness and implementation for autism and related neurodevelopmental conditions through coordinated, large-scale research.\u00a0<\/p>\n<p>\u201cBuilding the infrastructure to accelerate therapies for autistic people \u2014 particularly those with profound autism \u2014 requires exactly the kind of scientific depth and clinical commitment that UCLA and CHLA bring to this network,&#8221; said Ekemini Riley, PhD, managing director of ARIA. &#8220;We are proud to have them as part of this inaugural wave of the ARIA IMPACT Network as we work to translate scientific discovery into real therapeutic progress.\u201d<\/p>\n<p>UCLA has been a leader in autism research for decades, and the UCLA Center for Autism Research and Treatment is internationally renowned for conducting pioneering investigations. Joining the ARIA IMPACT Network will be another significant research milestone and will involve recruiting and following participants from 0-18 years of age over multiple years; collecting standardized clinical, behavioral, biomarker and genetic data; and contributing biospecimens and high-quality datasets to a centralized research platform. By combining highly detailed clinical and biological assessments with open data sharing across sites, the study aims to build a lasting scientific resource that strengthens clinical trial readiness and supports the development of more precise and effective interventions. Furthermore, feedback will be provided to families throughout their participation.\u00a0<\/p>\n<p>The UCLA co-Principal Investigators are Dr. <a href=\"https:\/\/www.uclahealth.org\/providers\/rajsekar-rajaraman\" rel=\"nofollow noopener\" target=\"_blank\">Rajsekar Rajaraman<\/a>, associate professor in pediatric neurology and psychiatry at the David Geffen School of Medicine, and Dr.<a href=\"https:\/\/www.uclahealth.org\/providers\/rujuta-wilson\" rel=\"nofollow noopener\" target=\"_blank\"> Rujuta B. Wilson<\/a>, assistant professor in pediatrics and psychiatry at the David Geffen School of Medicine. They will be working closely with PI Dr. Jonathan Santoro, chief of the division of neurology and co-director of the neurological institute at CHLA. The IMPACT-LA site brings together the expertise of both institutions and will help strengthen the framework for autism research throughout the region.<\/p>\n<p>\u201cThrough this important work, we will produce leading-edge research and accelerate understanding and treatment for patients with autism and related genetic conditions,\u201d said Dr. Wilson. \u201cIt is an honor to collaborate with Dr. Santoro and our peers at CHLA, as well as the other IMPACT sites, to conduct this work at a level never done before.\u201d<\/p>\n<p>\u201cHistorically, many studies have focused on verbal, higher-functioning individuals, leaving other populations underrepresented,\u201d said Dr. Rajaraman. \u201cThe IMPACT Network will provide the structure and datasets required for rigorous and inclusive clinical trials, addressing a long-standing need in autism research.\u201d\u00a0<\/p>\n<p>In addition to acting as a research site, UCLA, in partnership with Boston Children\u2019s Hospital, serves as the Clinical Coordinating Center (CCC) that oversees the IMPACT Network. In this role, UCLA will help oversee operations, provide administrative leadership and create an environment in which clinical research can be designed, conducted and disseminated effectively and efficiently.<\/p>\n<p>Dr. <a href=\"https:\/\/www.uclahealth.org\/providers\/shafali-jeste\" rel=\"nofollow noopener\" target=\"_blank\">Shafali Jeste<\/a>, chair of the department of pediatrics at the David Geffen School of Medicine at UCLA and executive director of the Children\u2019s Discovery and Innovation Institute, co-leads the CCC. \u201cI am thrilled that UCLA will not only provide the administrative backbone of this visionary project but also participate as one of the sites working in concert to ultimately deliver more effective therapies. Partnering with CHLA builds a bridge in autism research across Los Angeles, and together we will drive this important work forward with our peers worldwide.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Key takeaways UCLA\/CHLA have been selected to partner as one of the first 12 international sites to participate&hellip;\n","protected":false},"author":2,"featured_media":371522,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[48,52,51,47,50,49],"class_list":["post-371521","post","type-post","status-publish","format-standard","has-post-thumbnail","category-los-angeles","tag-la","tag-la-headlines","tag-la-news","tag-los-angeles","tag-los-angeles-headlines","tag-los-angeles-news"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/posts\/371521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/comments?post=371521"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/posts\/371521\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/media\/371522"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/media?parent=371521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/categories?post=371521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-ca\/wp-json\/wp\/v2\/tags?post=371521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}